Pharmaceutical Industry Newsletter

Be informed about the latest challenges and trends in the pharmaceutical industry from the periodical conducted by experts from PricewaterhouseCoopers and its correspondent law firm Réti, Antall and Madl Landwell. We publish the Newsletter in those periods when a lot of changes happen in the pharmaceutical industry. Contents of the latest issue - August 2009: The accounting of research and development expenditure at the fulfilment of the 12% payment obligation and the medical sales representatives’ fee

Pharmaceutical Newsletter - August 2009 (110 KB)

Previous issues:

Pharmaceutical Industry Newsletter January 2009

Contents:

• Changes affecting payment obligations in Act XCVIII of 2006 on the safe and economical supply of medicinal products and medical devices and the general rules on the distribution of medicines
• Accounting for payments under the volume subsidy agreement
• New company car tax regulations
• All for Patent Protection: The patent-related findings of the pharmaceutical sector inquiry
• Amendments to the legal regulation of Product Promotion

Pharmaceutical Industry Newsletter October 2008

Contents:

• The effect of the new advertising regulations on the marketing of pharmaceuticals
• Expected changes in payment obligations in connection with the promotion of pharmaceuticals
• Practical issues regarding the assumption of payment obligation by distributors

Pharmaceutical Industry Newsletter June 2008

Contents:

• Ruling of the Constitutional Court
• Concerns regarding the VAT treatment of clinical trials
• Practical issues regarding the assumption of payment obligation by distributors
• Changing advertising rules
• Certain legal aspects of generic competition

• Annual payment obligation for 2007 regarding pharmaceutical taxes
• Issues concerning data supply to the Health Insurance Supervisory Authority
• Changing VAT treatment for charitable donations and social responsibility initiatives
• Dawn Raids in Drug Promotion

• Payment obligation of foreign companies
• New Promotion Decree in Effect
• Non-Interventional Trials Now Require Licensing
• Therapeutical aids – new ranges of products involved in promotion regulation
• Information and Data Security in the Pharmaceutical Industry
• Measuring and Comparing Effectiveness of HR Management

• License for promotion of prescription medicines versus registration of medical sales representatives
• Advertising, information provision, donations - system of rules and execution
• Repayment obligation associated with exceeding the pharmaceutics allotment
• Changes in pharmaceutics promotion rules
• The use of financial modeling in the evaluation of the effects of the new regulations to enable the right set of management decisions

• Legal and ethical compliance of marketing strategies
• IFRS issues: Cooperation and strategic alliances in the pharmaceutical industry
• Working capital management in the pharmaceutical industry
• Tax treatement of clinical trials